Clinical trial
Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Egyptian Cirrhotic Patients With Ascites
NCT04785755 is registered in ClinicalTrials.gov with Hala Abd EL-Tawab Ibrahim Radwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Egyptian Cirrhotic Patients With Ascites
- Lead sponsor
- Hala Abd EL-Tawab Ibrahim Radwan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2017
- Completion date
- April 30, 2020
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatic ascites